Gene-activated Matrix for Bone Tissue Repair in Maxillofacial Surgery

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to evaluate safety and efficacy of gene-activated matrix (\"Nucleostim\") for regeneration of bone tissue in maxillofacial area. Patients with congenital and acquired maxillofacial defects (sockets of extracted teeth, bone defects after injuries, surgeries, excision of benign neoplasms and pseudotumors, etc.) or alveolar bone atrophy will be included into the study.
Epistemonikos ID: 47e693be7ff6b8dd1360cb8f4f6eaa696cdc043c
First added on: May 12, 2024